Human metabolic transformation of quercetin blocks its capacity to decrease endothelial nitric oxide synthase (eNOS) expression and endothelin-1 secretion by human endothelial cells.

The major dietary flavonol quercetin, which has been shown to improve endothelial function and decrease blood pressure, is extensively metabolized during absorption. This study examined the relative abilities of quercetin and its human metabolites to modulate the expression of eNOS and ET-1, which are involved in regulating endothelial homeostasis. Quercetin aglycone significantly reduced both eNOS protein and gene expression in HUVEC, mirroring the effects of the pro-inflammatory cytokine TNFα. In the presence of TNFα the aglycone caused further reductions in eNOS, whereas the metabolites were without effect in either TNFα-stimulated or unstimulated cells. ET-1 expression was significantly reduced by quercetin in both TNFα-stimulated or unstimulated HUVECs. The metabolites had no effect on ET-1 expression with the exception of quercetin-3'-sulfate, which caused a moderate increase in TNFα-stimulated cells. These results suggest that metabolic transformation of quercetin prevents it from causing a potentially deleterious decrease in eNOS in endothelial cells.

[1]  S. Ebeler,et al.  UHPLC-(ESI)QTOF MS/MS profiling of quercetin metabolites in human plasma postconsumption of applesauce enriched with apple peel and onion. , 2012, Journal of agricultural and food chemistry.

[2]  F. Perez-Vizcaino,et al.  The flavonoid paradox: conjugation and deconjugation as key steps for the biological activity of flavonoids. , 2012, Journal of the science of food and agriculture.

[3]  L. Moreno,et al.  Vascular deconjugation of quercetin glucuronide: the flavonoid paradox revealed? , 2011, Molecular nutrition & food research.

[4]  P. Kroon,et al.  Quercetin and its principal metabolites, but not myricetin, oppose lipopolysaccharide‐induced hyporesponsiveness of the porcine isolated coronary artery , 2011, British journal of pharmacology.

[5]  Weina Gao,et al.  Cholesterol metabolism is modulated by quercetin in rats. , 2011, Journal of agricultural and food chemistry.

[6]  G. Douglas,et al.  The pathogenesis of atherosclerosis , 2010 .

[7]  Takafumi Inoue,et al.  Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. , 2010, Free radical biology & medicine.

[8]  G. Tucker,et al.  Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. , 2010, The British journal of nutrition.

[9]  J. Hodgson,et al.  Specific Dietary Polyphenols Attenuate Atherosclerosis in Apolipoprotein E–Knockout Mice by Alleviating Inflammation and Endothelial Dysfunction , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[10]  P. Kroon,et al.  Quercetin and its major metabolites selectively modulate cyclic GMP‐dependent relaxations and associated tolerance in pig isolated coronary artery , 2010, British journal of pharmacology.

[11]  L. Moreno,et al.  Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. , 2009, Atherosclerosis.

[12]  J. Schrezenmeir,et al.  Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study , 2009, British Journal of Nutrition.

[13]  Bochu Wang,et al.  DNA binding and oxidative DNA damage induced by a quercetin copper(II) complex: potential mechanism of its antitumor properties , 2009, JBIC Journal of Biological Inorganic Chemistry.

[14]  P. Kroon,et al.  Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. , 2009, Atherosclerosis.

[15]  J. Hodgson,et al.  Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. , 2008, The American journal of clinical nutrition.

[16]  J. Salonen,et al.  Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study , 2008, International journal of cancer.

[17]  Ian Harvey,et al.  Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. , 2008, The American journal of clinical nutrition.

[18]  F. Perez-Vizcaino,et al.  Glucuronidated metabolites of the flavonoid quercetin do not auto-oxidise, do not generate free radicals and do not decrease nitric oxide bioavailability. , 2008, Planta medica.

[19]  J. Hodgson,et al.  Quercetin and its in vivo metabolites inhibit neutrophil-mediated low-density lipoprotein oxidation. , 2008, Journal of agricultural and food chemistry.

[20]  N. Shibata,et al.  Macrophage as a Target of Quercetin Glucuronides in Human Atherosclerotic Arteries , 2008, Journal of Biological Chemistry.

[21]  Moira A. Taylor,et al.  Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. , 2008, Atherosclerosis.

[22]  J. Hodgson,et al.  Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. , 2008, Biochemical pharmacology.

[23]  S. Litwin,et al.  Quercetin reduces blood pressure in hypertensive subjects. , 2007, The Journal of nutrition.

[24]  F. Mattivi,et al.  A novel model to study the biological effects of red wine at the molecular level , 2007, British Journal of Nutrition.

[25]  P. Kroon,et al.  Convenient syntheses of metabolically important quercetin glucuronides and sulfates , 2006 .

[26]  R. Venema,et al.  Quercetin inhibits eNOS, microtubule polymerization, and mitotic progression in bovine aortic endothelial cells. , 2006, The Journal of nutrition.

[27]  D. Barron,et al.  Divergent effects of quercetin conjugates on angiogenesis , 2006, British Journal of Nutrition.

[28]  S. Litwin,et al.  Quercetin-Supplemented Diets Lower Blood Pressure and Attenuate Cardiac Hypertrophy in Rats With Aortic Constriction , 2006, Journal of cardiovascular pharmacology.

[29]  J. Tamargo,et al.  Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats , 2006, Journal of hypertension.

[30]  C. Edwards,et al.  Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions , 2006, British Journal of Nutrition.

[31]  J. Fish,et al.  Epigenetic Basis for the Transcriptional Hyporesponsiveness of the Human Inducible Nitric Oxide Synthase Gene in Vascular Endothelial Cells1 , 2005, The Journal of Immunology.

[32]  K. Naseem.  The role of nitric oxide in cardiovascular diseases. , 2005, Molecular aspects of medicine.

[33]  V. Schini-Kerth,et al.  Vascular protection by dietary polyphenols. , 2004, European journal of pharmacology.

[34]  G. Williamson,et al.  How should we assess the effects of exposure to dietary polyphenols in vitro? , 2004, The American journal of clinical nutrition.

[35]  J. Duarte,et al.  Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats , 2004, Molecular and Cellular Biochemistry.

[36]  J. Tamargo,et al.  Nitric oxide (NO) scavenging and NO protecting effects of quercetin and their biological significance in vascular smooth muscle. , 2004, Molecular pharmacology.

[37]  E. Choi,et al.  Anti- and prooxidant effects of chronic quercetin administration in rats. , 2003, European journal of pharmacology.

[38]  G. Yen,et al.  Pro-oxidative Properties of Flavonoids in Human Lymphocytes , 2003, Bioscience, biotechnology, and biochemistry.

[39]  W. Klaus,et al.  Nitric Oxide Formation and Corresponding Relaxation of Porcine Coronary Arteries Induced by Plant Phenols: Essential Structural Features , 2002, Journal of cardiovascular pharmacology.

[40]  J. Tamargo,et al.  Endothelium-independent vasodilator effects of the flavonoid quercetin and its methylated metabolites in rat conductance and resistance arteries. , 2002, The Journal of pharmacology and experimental therapeutics.

[41]  Martin J. Carrier,et al.  Health: Endothelin-1 synthesis reduced by red wine , 2001, Nature.

[42]  K. Shimoi,et al.  Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[43]  W. Sly,et al.  Flavonoid glucuronides are substrates for human liver β‐glucuronidase , 2001 .

[44]  K. O'Leary,et al.  Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4'-glucoside. , 2001, The Journal of nutrition.

[45]  J. Tamargo,et al.  Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats , 2001, British journal of pharmacology.

[46]  F. Hu,et al.  Dietary modulation of endothelial function: implications for cardiovascular disease. , 2001, The American journal of clinical nutrition.

[47]  D. Barron,et al.  Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin , 2001, Free radical research.

[48]  C. Yuan,et al.  Effects of quercetin on the release of endothelin, prostacyclin and tissue plasminogen activator from human endothelial cells in culture. , 1999, Journal of ethnopharmacology.

[49]  K. Hirata,et al.  Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression. , 1998, Hypertension.

[50]  R. Ross,et al.  Atherosclerosis is an Inflammatory Disease , 1998 .

[51]  M. Chiesi,et al.  Inhibition of constitutive endothelial NO-synthase activity by tannin and quercetin. , 1995, Biochemical pharmacology.

[52]  S. Moncada,et al.  The L-arginine-nitric oxide pathway. , 1993, The New England journal of medicine.

[53]  H. Rus,et al.  Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. , 1991, Atherosclerosis.

[54]  I. Arts,et al.  Some phenolic compounds increase the nitric oxide level in endothelial cells in vitro. , 2009, Journal of agricultural and food chemistry.

[55]  J. Segura-Aguilar,et al.  Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. , 1999, Free radical biology & medicine.

[56]  R. Prior,et al.  Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. , 1997, Free radical biology & medicine.

[57]  D Kromhout,et al.  Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. , 1993, Nutrition and cancer.